Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. J. McKiernan, O. Cunningham, N. G. McElvaney, S. A. Cryan, C. M. Greene (Dublin, Ireland). Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Eur Respir J 2012; 40: Suppl. 56, 3723

Member's Comments

No comment yet.

Related content which might interest you: Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells Source: Eur Respir J 2015; 45: 428-439 Year: 2015 CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020 Proteomics characterisation of nasal epithelial cells in cystic fibrosis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Targeting aENaC with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008 Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016 Year: 2017 Novel therapeutics for cystic fibrosis Source: ERS Webinar 2020: Novel therapeutics for cystic fibrosis Year: 2020 Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Epithelial cell regulation of immunity in cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019 Year: 2021 Modeling the regenerative potential of airway epithelial cells Source: Virtual Congress 2020 – (Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration Year: 2020 microRNA-mediated inhibition of IL-8 production from cystic fibrosis bronchial epithelial cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Targeting CFTR as a therapy for cystic fibrosis Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020